TrialPsychopharmacology2014

A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.

Mehdi Farokhnia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.